InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,298.77
(
0.99%
)
US TECH 100
18,097.20
(
1.46%
)
Dow Jones
39,824.79
(
0.67%
)
Brent Oil
82.60
(
0.05%
)
Bitcoin
65,330.41
(
6.15%
)
Post# of 251825
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 159074

Wednesday, 04/03/2013 3:09:31 AM

Wednesday, April 03, 2013 3:09:31 AM

Post# of 251825

The Teva-Lonza FoB collaboration announced in 2009 (#msg-34930012) appears to be dead, for all practical purposes

After the discontinuation of TL011 (the JV's Rituxan knockoff) phase III in Oct 2012, and the hardly mentioned FoB program on Teva's analyst day in Dec 2012, it's not surprising.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up